Anaemia during pregnancy Pregnancy and Childbirth Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium
Conditions
Interventions
The participating villages will be randomly allocated to the following two groups:
Supplementary group will receive supplementary food, 400 mg albendazole, and health and nutrition
education. The av
Sponsors
Nestle Foundation (Switzerland)
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. Pregnant women, gestation 12-20 weeks 2. Age 15-49 years 3. No existing severe maternal illness
Exclusion criteria
Exclusion criteria: 1. Suffer from chronic disease 2. In medication/antibiotic treatment 3. Do not sign inform consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Maternal iron status at gestation 12-20 week: 1. Haemoglobin 2. Ferritin 3. Soluble transferrin receptors | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Infectious status at gestation 12-20 weeks and 32-36 weeks: 1.1. C-reactive protein 1.2. A-1 acid glycoprotein 2. Helminth infestation (hookworms, A.lumbricoides, T.trichiura) measured quantitatively (eggs per gram) at gestation 12-20 weeks and 32-36 weeks 3. Gestational age calculated from date of last menstruation and palpation 4. Weight gain of pregnant women and birth weight of infant will be measured with electronic weighing scale 5. Length of infant will be measured with length board 6. Complication deliveries/fetal loss will be measured with verbal autopsy interviews, less than 3 days after delivery | — |
Countries
Indonesia
Outcome results
None listed